“…We hypothesized that serum sphingolipids would be altered with asthma symptoms, EIW, and asthma persistence among a case-control study of children with and without asthma, the New York City Neighborhood Asthma and Allergy Study, described previously (4). Briefly, during home visits, spirometry, fractional exhaled nitric oxide testing, and waist circumference measurements were conducted and serum was collected in 7-to 8-year-old children.…”